Benjamin Rix Brooks
About
Benjamin Rix Brooks is a scholar working on Neurology, Genetics and Molecular Biology.
According to data from OpenAlex, Benjamin Rix Brooks has authored 157 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Neurology, 44 papers in Genetics and 25 papers in Molecular Biology. Recurrent topics in Benjamin Rix Brooks's work include Amyotrophic Lateral Sclerosis Research (92 papers), Neurogenetic and Muscular Disorders Research (43 papers) and Parkinson's Disease Mechanisms and Treatments (26 papers). Benjamin Rix Brooks is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (92 papers), Neurogenetic and Muscular Disorders Research (43 papers) and Parkinson's Disease Mechanisms and Treatments (26 papers). Benjamin Rix Brooks collaborates with scholars based in United States, Canada and United Kingdom. Benjamin Rix Brooks's co-authors include Michael Swash, Theodore L. Munsat, Robert G. Miller, Duard L. Walker, Hiroshi Mitsumoto, Robert Sufit, Peter V. Rabins, Walter G. Bradley, Roxanne DePaul and Robert G. Miller and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
In The Last Decade
Benjamin Rix Brooks
157 papers receiving 12.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Benjamin Rix Brooks United States | 46 | 9.2k | 4.8k | 1.8k | 1.8k | 1.5k | 157 | 12.5k | ||
| Robert G. Miller United States | 46 | 6.9k 0.7× | 3.4k 0.7× | 1.5k 0.8× | 1.3k 0.7× | 1.5k 1.0× | 114 | 9.9k | ||
| Hiroshi Mitsumoto United States | 62 | 10.1k 1.1× | 6.0k 1.2× | 4.0k 2.2× | 1.7k 1.0× | 2.4k 1.6× | 252 | 15.2k | ||
| Reinhard Dengler Germany | 59 | 6.8k 0.7× | 2.1k 0.4× | 2.0k 1.1× | 1.5k 0.8× | 2.8k 1.9× | 378 | 12.4k | ||
| Martin R. Turner United Kingdom | 63 | 10.7k 1.2× | 4.9k 1.0× | 3.1k 1.7× | 2.2k 1.2× | 2.0k 1.3× | 262 | 14.2k | ||
| Andrew Eisen Canada | 62 | 8.5k 0.9× | 3.3k 0.7× | 2.4k 1.3× | 1.6k 0.9× | 2.5k 1.7× | 243 | 15.1k | ||
| Vincenzo Silani Italy | 55 | 7.8k 0.8× | 4.5k 0.9× | 4.4k 2.4× | 1.5k 0.8× | 3.1k 2.1× | 369 | 12.9k | ||
| Leonard H. van den Berg Netherlands | 62 | 8.9k 1.0× | 4.3k 0.9× | 3.3k 1.8× | 1.7k 0.9× | 2.7k 1.8× | 260 | 12.9k | ||
| Adriano Chiò Italy | 75 | 16.6k 1.8× | 9.6k 2.0× | 4.9k 2.7× | 2.6k 1.5× | 2.2k 1.5× | 381 | 20.7k | ||
| Jan Kassubek Germany | 60 | 7.6k 0.8× | 1.7k 0.4× | 1.7k 0.9× | 1.4k 0.8× | 3.0k 2.0× | 437 | 13.6k | ||
| Sharon Abrahams United Kingdom | 53 | 5.9k 0.6× | 1.9k 0.4× | 1.4k 0.8× | 1.9k 1.1× | 928 0.6× | 169 | 10.3k |
Countries citing papers authored by Benjamin Rix Brooks
Since
Specialization
Citations
This map shows the geographic impact of Benjamin Rix Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Rix Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Rix Brooks more than expected).
Fields of papers citing papers by Benjamin Rix Brooks
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Benjamin Rix Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Rix Brooks. The network helps show where Benjamin Rix Brooks may publish in the future.
Co-authorship network of co-authors of Benjamin Rix Brooks
This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Rix Brooks. A scholar is included among the top collaborators of Benjamin Rix Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Rix Brooks. Benjamin Rix Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Pioro, Erik P., et al.. (2024). Efficacy of Radicava® IV (intravenous edaravone) in subjects with differing trajectories of disease progression in amyotrophic lateral sclerosis: Use of a novel statistical approach for post hoc analysis of a pivotal phase 3 clinical trial. Journal of the Neurological Sciences. 467. 123290–123290.
2.
Benatar, Michael, Tracie A. Caller, Rohit Das, et al.. (2023). Amyotrophic Lateral Sclerosis Quality Measurement Set 2022 Update. Neurology. 101(5). 223–232.
3.
Mehta, Paul, Jaime Raymond, Reshma Punjani, et al.. (2022). A revision to the United States national ALS registry’s algorithm to improve Case-Ascertainment. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 24(3-4). 230–236.
4.
Oskarsson, Björn, Nicholas J. Maragakis, Richard Bedlack, et al.. (2021). MN-166 (ibudilast) in Amyotrophic Lateral Sclerosis in a Phase IIb/III Study: COMBAT-ALS Study Design. Neurodegenerative Disease Management. 11(6). 431–443.
5.
Wright, Kathryn, et al.. (2019). Dextromethorphan-Quinidine (Nuedexta) Improves Swallowing in Bulbar Onset ALS Patients with Pseudobulbar Affect - Pre-Post Observational Study in 86 ALS Patients (P4.4-019). Neurology. 92(15_supplement).
6.
Brooks, Benjamin Rix, Michael J. M. Fischer, Mohammed Sanjak, et al.. (2014). Serum Creatinine, a Biomarker for Muscle Mass in Amyotrophic Lateral Sclerosis (ALS), Predicts Loss of Ambulation Measured by ALS Functional Rating Scale-Revised Walking Item Score (ALSFRS-Rw) (P4.085). Neurology. 82(10_supplement).
7.
Turner, Martin R., Orla Hardiman, Michael Benatar, et al.. (2013). Controversies and priorities in amyotrophic lateral sclerosis. The Lancet Neurology. 12(3). 310–322.
8.
Bravver, Elena, Mohammed Sanjak, & Benjamin Rix Brooks. (2013). Disease Severity and Disease Trajectory of Amyotrophic Lateral Sclerosis (ALS) Patients at Frist Clinic Visit Measured Prospectively with "ALS Dashboard" – A Six-Domain (Cognition, Affect, Bulbar, Respiratory, Arm, Leg) Staging System – Comparison of Two Cohorts (P07.088). Neurology. 80(7_supplement).
9.
Bravver, Elena, Charlotte L. Craig, Nicole Williams, et al.. (2013). The Joint Commission (TJC)/Disease-Specific Care (DSC) Certification Programs for Parkinson's Disease (PD)/Multiple Sclerosis (MS)/Amyotrophic Lateral Sclerosis (ALS) – A Structured Mechanism Developed for Guideline-Directed Performance Measure Implementation, Audit and Compliance Assessment Allowing Evolution from Process-Based to Patient-Outcome-Based Improvement in Patient Care at Carolinas Medical Center (P04.189). Neurology. 80(7_supplement).
10.
Hammond, Edward R., Carolyn Young, Adriano Chiò, et al.. (2013). Evaluation of a Health State Staging System Defined by Loss of Independence in Amyotrophic Lateral Sclerosis: Assessment in a Second Dataset. Oxford University Research Archive (ORA) (University of Oxford).
11.
Crumpacker, David W., et al.. (2013). PRISM: A Novel Tool to Prospectively Estimate the Prevalence of Pseudobulbar Affect Symptoms. American Journal of Geriatric Psychiatry. 21(3). S128–S129.
12.
Montcel, Sophie Tézenas du, Nathalie Lévêque, Timothée Lenglet, et al.. (2012). Validation of robust tools to measure sialorrhea in amyotrophic lateral sclerosis: A study in a large French cohort. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 14(4). 302–307.
13.
Gallagher, Catherine L., Sterling C. Johnson, Barbara B. Bendlin, et al.. (2011). A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson’s disease. Brain Imaging and Behavior. 5(3). 203–211.
14.
Sanjak, Mohammed, Agnieszka Wacławik, Hans E. Neville, et al.. (2001). Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis. Journal of the Neurological Sciences. 191(1-2). 55–59.
15.
Miller, Robert G., Theodore L. Munsat, Michael Swash, & Benjamin Rix Brooks. (1999). Consensus guidelines for the design and implementation of clinical trials in ALS. Journal of the Neurological Sciences. 169(1-2). 2–12.
16.
Rozental, Jack M., et al.. (1989). Neuropeptide degradation by large vessel and microvessel-derived endothelial cells in vitro: cell surface catabolism of thyrotropin releasing hormone (TRH). Brain Research. 499(2). 397–401.
17.
Rabins, Peter V., Benjamin Rix Brooks, Godfrey D. Pearlson, et al.. (1986). STRUCTURAL BRAIN CORRELATES OF EMOTIONAL DISORDER IN MULTIPLE SCLEROSIS. Brain. 109(4). 585–597.
18.
Rabins, Peter V., et al.. (1983). Disease activity and emotional state in multiple sclerosis. Annals of Neurology. 13(5). 573–577.
19.
Cohen, Steven R., Benjamin Rix Brooks, Burk Jubelt, Robert M. Herndon, & Guy M. McKhann. (1980). Myelin Basic Protein in Cerebrospinal Fluid Index of Active Demyelination.
20.
Brooks, Benjamin Rix & Duard L. Walker. (1963). Progressive Multifocal Leukoencephalopathy. JAMA. 183(9). 181–181.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Robert G. Miller Breakdown of academic impact, for papers by Hiroshi Mitsumoto Breakdown of academic impact, for papers by Reinhard Dengler Breakdown of academic impact, for papers by Martin R. Turner Breakdown of academic impact, for papers by Andrew Eisen Breakdown of academic impact, for papers by Vincenzo Silani Breakdown of academic impact, for papers by Leonard H. van den Berg Breakdown of academic impact, for papers by Adriano Chiò Breakdown of academic impact, for papers by Jan Kassubek Breakdown of academic impact, for papers by Sharon Abrahams